Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
131.49
Oct 29 • 3:59 PM ET Dollar change+9.40 Percentage change(7.70%)
Aftermarket Close
131.49
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Oct 29, 10:38 PMEncompass Health raises 2026 guidance on strong volume, acuity mix, and labor efficiencies
Index
-
Market Cap
12.97B
Enterprise Value
16.56B
Income
643.10M
Sales
6.34B
Book/sh
26.29
Cash/sh
1.02
Employees
42300
IPO
Sep 24, 1986
P/E
20.53
Forward P/E
19.25
PEG
1.75
P/S
2.05
P/B
5.00
P/C
129.46
P/FCF
28.37
EV/EBITDA
10.88
EV/Sales
2.61
Quick Ratio
1.19
Current Ratio
1.09
Debt/Eq
1.05
LT Debt/Eq
1.02
Option/Short
Yes / Yes
EPS (ttm)
6.40
EPS next Y
6.83
EPS next Q
1.60
EPS this Y
14.12%
EPS next Y
9.83%
EPS next 5Y
11.03%
EPS past 3/5Y
27.08% 14.24%
Sales past 3/5Y
10.92% 5.03%
EPS Y/Y TTM
20.85%
Sales Y/Y TTM
9.36%
EPS Q/Q
21.30%
Sales Q/Q
8.93%
Insider Own
1.01%
Insider Trans
-19.37%
Inst Own
98.23%
Inst Trans
-0.79%
ROA
8.70%
ROE
24.84%
ROIC
11.89%
Gross Margin
22.25%
Oper. Margin
18.32%
Profit Margin
10.15%
SMA20
6.13%
SMA50
7.30%
SMA200
19.68%
Trades
Shs Outstand
98.65M
Shs Float
97.65M
52W High
129.96 1.18%
52W Low
92.77 41.74%
Volatility
2.92% 2.75%
ATR (14)
3.82
RSI (14)
64.30
Beta
0.86
Rel Volume
2.30
Avg Volume
956.55K
Volume
2,197,689
Perf Week
4.35%
Perf Month
8.23%
Perf Quarter
18.38%
Perf Half Y
31.49%
Perf YTD
23.88%
Perf Year
4.66%
Perf 3Y
116.09%
Perf 5Y
160.19%
Perf 10Y
316.88%
Prev Close
122.09
Price
131.49
Change %
7.70%
Consensus
Strong Buy
Avg. Price Target
$153.08
Implied Upside
+16.4%
Analysts14incl. previous ratings
Rating Distribution12 Buy · 1 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
May 28, 2026Initiated
TD logoTTD Cowen
Buy$125-4.9%
Oct 11, 2024Initiated
KEY logoKKeyBanc Capital Markets
Overweight$115-12.5%
Jul 10, 2024Initiated
LLeerink Partners
Outperform$100-23.9%
Mar 06, 2024Initiated
BCS logoBBarclays
Overweight$95-27.8%
Mar 14, 2023Initiated
BCS logoBBarclays
Equal Weight$57-56.7%
Sep 24, 2021Initiated
UBS logoUUBS
Buy$98-25.5%
Aug 02, 2021Upgrade
RJF logoRRaymond James
Outperform → Strong Buy$95 → $107-18.6%
Nov 23, 2020Upgrade
BCS logoBBarclays
Equal Weight → Overweight$96-27.0%
Aug 20, 2020Resumed
BCS logoBBarclays
Equal Weight$71-46.0%
Dec 11, 2019Downgrade
WFC logoWWells Fargo
Market Perform → Underperform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Price Andrew LChief Accounting OfficerAug 31 '26Sale120.935,211630,16669,483Sep 01 12:21 PM
Darby John PatrickEVP, Gen Counsel & SecretaryAug 31 '26Option Exercise35.064,858170,32179,899Sep 01 12:21 PM
Darby John PatrickEVP, Gen Counsel & SecretaryAug 31 '26Sale121.094,858588,25575,041Sep 01 12:21 PM
John Patrick DarbyOfficerAug 31 '26Proposed Sale121.094,858588,256Aug 31 12:40 PM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerAug 10 '26Sale125.3818,8692,365,79550,508Aug 11 02:47 PM
Tarr Mark JPresident & CEOAug 10 '26Sale125.47173,14821,724,095267,814Aug 11 02:47 PM
Darby John PatrickEVP, Gen Counsel & SecretaryAug 10 '26Sale125.958,9061,121,71175,041Aug 11 02:47 PM
Mark TarrOfficerAug 10 '26Proposed Sale125.45173,14821,722,175Aug 10 05:23 PM
John Patrick DarbyOfficerAug 10 '26Proposed Sale125.958,9061,121,701Aug 10 05:20 PM
Douglas ColtharpOfficerAug 10 '26Proposed Sale125.3818,8692,365,701Aug 10 05:10 PM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Option Exercise32.9427,694912,24097,071May 18 01:16 PM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Sale106.8327,6942,958,55069,377May 18 01:16 PM
Douglas Edward ColtharpOfficerMay 15 '26Proposed Sale106.8327,6942,958,629May 15 01:19 PM
Tuer Patrick WilliamEVP, Chief Operating OfficerMay 11 '26Sale104.5668271,31024,755May 12 04:16 PM
Patrick TuerOfficerMay 11 '26Proposed Sale104.5668271,312May 11 05:30 PM
Fay EdmundSr. Vice Pres. and TreasurerMar 09 '26Sale107.0011,9371,277,25989,325Mar 10 01:43 PM
Tarr Mark JPresident & CEOFeb 11 '26Sale111.64150,00016,746,688377,070Feb 12 03:40 PM
Mark TarrOfficerFeb 11 '26Proposed Sale111.59150,00016,738,961Feb 11 03:05 PM
Tuer Patrick WilliamEVP, Chief Operating OfficerFeb 10 '26Sale107.622,804301,76616,042Feb 10 04:30 PM
Patrick TuerOfficerFeb 10 '26Proposed Sale107.622,804301,755Feb 10 02:24 PM
Encompass Health Corp. engages in the provision of post-acute healthcare services. It provides specialized rehabilitative treatment on an inpatient basis. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
CEOMr. Mark J. Tarr
Executive VP & CFOMr. Douglas E. Coltharp
Executive VP & COOMr. Patrick W. Tuer
Executive VPMr. John Patrick Darby
M.S.Dr. Elissa Joy Charbonneau D.O.